Axogen [AXGN] vs Artivion [AORT] Detailed Stock Comparison

Axogen Inc.

NASDAQ
Loading...

Artivion Inc.

NYSE
Loading...

TLDR: Quick Comparison Summary

Based on 20 vital metrics comparison: Axogen Inc. wins in 5 metrics, Artivion Inc. wins in 14 metrics, with 0 ties. Artivion Inc. appears stronger overall.

View Metrics Details

Vital Metrics Comparison

Metric Axogen Inc. Artivion Inc. Better
P/E Ratio (TTM) -110.18 179.71 Artivion Inc.
Price-to-Book Ratio 13.15 4.03 Artivion Inc.
Debt-to-Equity Ratio 55.50 57.67 Axogen Inc.
PEG Ratio 0.04 -1.59 Axogen Inc.
EV/EBITDA -2,165.44 36.67 Artivion Inc.
Profit Margin (TTM) -6.97% 2.21% Artivion Inc.
Operating Margin (TTM) -16.31% 8.09% Artivion Inc.
EBITDA Margin (TTM) N/A 8.09% N/A
Return on Equity -13.49% 2.70% Artivion Inc.
Return on Assets (TTM) -2.31% 2.34% Artivion Inc.
Free Cash Flow (TTM) $-4.78M $839,000 Artivion Inc.
1-Year Return 341.03% -28.85% Axogen Inc.
Price-to-Sales Ratio (TTM) 8.27 4.15 Artivion Inc.
Enterprise Value $1.89B $1.97B Artivion Inc.
EV/Revenue Ratio 8.40 4.47 Artivion Inc.
Gross Profit Margin (TTM) 74.13% 63.06% Axogen Inc.
Revenue per Share (TTM) $5 $10 Artivion Inc.
Earnings per Share (Diluted) $-0.34 $0.21 Artivion Inc.
Beta (Stock Volatility) 0.98 1.62 Axogen Inc.
Short % of Float 6.92% 4.13% Artivion Inc.

Axogen Inc. vs Artivion Inc. Stock Performance Analysis

Loading Price Chart...

AXGN
AORT

Performance Comparison

Short-term Returns

Stock1D1W1M3M6MYTD
Axogen Inc.1.72%5.50%6.71%33.19%46.88%41.10%
Artivion Inc.4.83%3.33%-7.47%-43.66%-53.56%-52.61%

Long-term Returns

Stock1Y3Y5Y10Y15Y20Y
Axogen Inc.341.03%367.90%106.53%628.81%1,769.57%12,185.71%
Artivion Inc.-28.85%25.55%-29.37%70.34%288.03%318.75%

Performance & Financial Health Analysis: Axogen Inc. vs Artivion Inc.

MetricAXGNAORT
Market Information
Market Cap i$1.94B$1.83B
Market Cap CategorySmall capSmall cap
10 Day Avg. Volume i1,245,238273,552
90 Day Avg. Volume i1,068,353406,554
Last Close$43.74$21.07
52 Week Range$9.22 - $45.83$19.16 - $48.25
% from 52W High-4.56%-56.33%
All-Time High$56.85 (Jul 23, 2018)$48.25 (Dec 17, 2025)
% from All-Time High-23.06%-56.33%
Growth Metrics
Quarterly Revenue Growth0.21%0.19%
Quarterly Earnings Growth0.21%0.19%
Financial Health
Profit Margin (TTM) i-0.07%0.02%
Operating Margin (TTM) i-0.16%0.08%
Return on Equity (TTM) i-0.13%0.03%
Debt to Equity (MRQ) i55.5057.67
Cash & Liquidity
Book Value per Share (MRQ)$2.73$9.37
Cash per Share (MRQ)$0.80$1.36
Operating Cash Flow (TTM) i$812,000$39.88M
Levered Free Cash Flow (TTM) i$3.58M$-20,097,624
Dividends
Last 12-Month Dividend Yield iN/AN/A
Last 12-Month Dividend i$0.00$0.00

Valuation & Enterprise Metrics Analysis: Axogen Inc. vs Artivion Inc.

MetricAXGN (Apr 24, 2026)AORT (Apr 26, 2026)
Price Ratios
P/E Ratio (TTM) i-110.18179.71
Forward P/E i47.3132.65
PEG Ratio i0.04-1.59
Price to Sales (TTM) i8.274.15
Price to Book (MRQ) i13.154.03
Market Capitalization
Market Capitalization i$1.94B$1.83B
Enterprise Value i$1.89B$1.97B
Enterprise Value Metrics
Enterprise to Revenue i8.404.47
Enterprise to EBITDA i-2,165.4436.67
Risk & Other Metrics
Beta i0.981.62
Book Value per Share (MRQ) i$2.73$9.37

Financial Statements Comparison: Axogen Inc. vs Artivion Inc.

Financial Metrics

Loading Financial Charts...

Revenue

Operating Margin

Profit Margin

Long Term Debt

Income Flow Analysis

Financial Statements Comparison

Income Statement

MetricAXGN (2025)AORT (2025)
Revenue/Sales i225.21M441.33M
Cost of Goods Sold i57.86M157.10M
COGS % of Revenue i25.7%35.6%
Gross Profit i167.35M284.23M
Gross Margin i74.3%64.4%
Research & Development i32.89M30.99M
Operating Income (EBIT) i-7.85M26.75M
Operating Margin i-3.5%6.1%
EBITDA i826,00059.48M
EBITDA Margin i0.4%13.5%
Pre-Tax Income i-15.70M14.78M
Pre-Tax Income % of Revenue i-7.0%3.3%
Income Tax iN/A5.01M
Income Tax % of Revenue i0.0%1.1%
Net Income (Profit) i-15.70M9.77M
Profit Margin i-7.0%2.2%

Balance Sheet & Liquidity Metrics

MetricAXGN (2025)AORT (2025)
Cash & Equivalents i35.55M64.91M
Total Current Assets i120.42M358.08M
Total Current Assets % of Revenue i53.5%81.1%
Total Current Liabilities i23.56M101.56M
Total Current Liabilities % of Revenue i10.5%23.0%
Long-Term Debt i65.26M252.24M
Long-Term Debt % of Revenue i29.0%57.2%
Total Shareholders Equity i128.85M448.23M
Retained Earnings i-306.96M-51.50M
Retained Earnings % of Revenue i-136.3%-11.7%
Property, Plant & Equipment i29.38M34.70M

Cash Flow Statement Comparison

MetricAXGN (2025)AORT (2025)
Operating Cash Flow i10.26M41.11M
Operating Cash Flow % of Revenue i4.6%9.3%
Capital Expenditures i-3.75MN/A
Free Cash Flow i-4.78M839,000
FCF Margin i-2.1%0.2%
Debt Repayment i-32,000-2.46M
Common Stock Repurchase iN/A0

Short Interest & Institutional Ownership Analysis

MetricAXGNAORT
Shares Short i3.50M1.67M
Short Ratio i4.044.28
Short % of Float i6.92%4.13%
Shares Outstanding i47.20M47.84M
Float Shares i50.75M45.40M
% Held by Insiders i2.12%4.52%
% Held by Institutions i88.11%91.48%
% Held by Public i9.77%4.00%

Dividend Analysis & Yield Comparison: Axogen Inc. vs Artivion Inc.

MetricAXGNAORT
Last 12-Month Dividend i$0.00$0.00
Last 12-Month Dividend Yield iN/AN/A
3-Year Avg Annual Dividend i$0.00$0.00
3-Year Avg Dividend Yield iN/AN/A
3-Year Total Dividends i$0.00$0.00
Ex-Dividend DateN/AN/A